What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Thalidomide
96%DGNews: Melphalan Better Partner With Bortezomib for Older Patients With Untreated Multiple Myeloma: Presented at ASH
96%DGNews: Addition of Thalidomide to Standard Therapy Improves Overall Survival in Newly Diagnosed Multiple Myeloma
96%DGNews: Clinical Data on Thalidomide Reported in Recurrent Epithelial Ovarian Cancer
95%DGNews: Thalidomide Provides a Durable Response and Survival Benefit Primarily in Patients With Low-Risk Myelodysplastic Disease: Presented at MDS
95%DGNews: Low-Dose Warfarin Decreases Incidence of Thalidomide-Associated Venous Thromboembolism in Patients With Multiple Myeloma: Presented at EHA
95%DGNews: Thalomid sNDA Granted FDA Approval For Treatment of Newly Diagnosed Multiple Myeloma
95%DGNews: Thalidomide Prolongs Survival in Patients With Extended-Disease Small-Cell Lung Cancer Who Respond to Chemotherapy: Presented at WCLC
95%DGNews: Australia Recommends Approval of Thalidomide For Treatment of Relapsed and Refractory Multiple Myeloma, and Complications of Leprosy
95%DGNews: CFS: Thalidomide Shows Promise in Treatment of Renal Cell Carcinoma
95%DGNews: Thalidomide Significantly Affects Early-stage Multiple Myeloma
95%DGNews: ASH: Thalomid (Thalidomide) Promising In Treating Refractory Multiple Myeloma
95%DGNews: Thalidomide Reduces Multiple Myeloma Progression
95%DGNews: Thalidomide Investigated For Various Types Of Cancer
95%DGNews: New Category of Anti-Inflammatory Drugs Derived from Thalidomide
95%DGNews: Thalidomide Now Approved By FDA For a Fourth Application
95%DGNews: IMW: Thalomid Shows Clinical Benefit In Multiple Myeloma
95%DGNews: Positive Prostate Cancer Interim Results In Clinical Trials With Thalidomide
94%DGNews: Thalidomide, Radiotherapy Compared to Reduce Risk of Metastases Following Prostatectomy
94%DGNews: Thalidomide Appears Safe for Men on Warfarin: Presented at ACCP
94%DGNews: First-Line Thalidomide Therapy Effective in Preparation for Autologous Stem Cell Transplantation in Young Patients With Symptomatic Multiple Myeloma: Presented at EHA
94%DGNews: Thalidomide Added to Standard Therapy Reduces Risk of Multiple Myeloma Recurrence
94%DGNews: SGO: Thalidomide Found Similar to Intravenous Chemotherapy in Heavily Pretreated Patients With Advanced Ovarian Cancer
94%DGNews: ASCO: Relapsed Mantle-Cell Lymphoma Responds to Rituximab and Thalidomide Therapy
94%DGNews: AACR-NCI-EORTC: Thalidomide + Celecoxib May Enhance Irinotecan's Antitumour Activity
94%DGNews: Thalidomide Therapy For Multiple Myeloma Patients May Lengthen Survival
94%DGNews: EntreMed's Thalidomide Analog Receives FDA Orphan Drug Designation for Multiple Myeloma
94%DGNews: IADRD: Pilot Study of Thalidomide for Alzheimer's Disease Fails to Detect Cognitive Benefit but Finds Effect on TNF-alpha
94%DGNews: DG DISPATCH - ASH: Thalidomide Plus Dexamethasone Has Potential As First-Line Therapy For Multiple Myeloma
94%DGNews: Thalomid Receives FDA Orphan Drug Designation For Crohn's Disease
94%DGNews: Thalidomide Clinical Trials Expanded
94%DGNews: ASH: Thalomid Reduces Tumor Burden In Patients With Advanced Multiple Myeloma
94%DGNews: Study Shows Thalidomide Heals Mouth Lesions In HIV Patients
94%DGNews: Steroid Dosages May Be Decreased When Thalomid Is Added To Crohn's Treatment
93%DGNews: Thalidomide Does Not Improve Survival in Small Cell Lung Cancer
93%DGNews: Australian Agency Approves Thalidomide for the Treatment of Newly Diagnosed Multiple Myeloma
93%DGNews: Thalidomide Shows Promise in Ovarian Cancer Treatment: Presented at SGO
93%DGNews: Combination of Two Existing Drugs Offers Potential Alternative for Prostate Cancer: Presented at AACR-NCI-EORTC
93%DGNews: ASCO: Thalidomide, Gemcitabine Combination Shows Benefit in Pancreatic Cancer
93%DGNews: ASH: Velcade-Thalidomide-Dexamethasone Regimen Shows Treatment Potential for End-Stage Myeloma
93%DGNews: ASH: Clarithromycin Augments Response to Dexamethasone With or Without Thalidomide in Advanced Multiple Myeloma
93%DGNews: Oral Drug Combination Proven as Effective as Standard Chemotherapy
93%DGNews: DDW: Thalidomide Shows Promise in Controlling Gastrointestinal Bleeding and Lowering Vascular Endothelial Growth Factor
93%DGNews: Thalomid (Thalidomide) Shows Promise In Myelodysplastic Syndromes
93%DGNews: ASCO: Thalidomide Promising in a Variety of Cancers
93%DGNews: ASCO MEETING: Thalomid Shows Activity In Recurrent Glioblastoma
93%DGNews: Thalomid (Thalidomide), TNF-alpha Modulators Show Promise in Inflammatory Bowel Disease
93%DGNews: Thalidomide Submitted for NDAs for Use In Leprosy and AIDS Cachexia
93%DGNews: DDW: Thalomid Active In Treating Crohn's Disease
93%DGNews: LSA MEETING: Thalidomide Promising For Multiple Myeloma Patients
93%DGNews: Thalidomid Shows Promise Against Multiple Myeloma In Relapsing Patients
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.